KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 83 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2013 | $242,000 | – | 5,300 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AlpInvest Partners B.V. | 48,087 | $1,575,000 | 4.91% |
Palo Alto Investors LP | 1,102,181 | $36,107,000 | 2.70% |
Aureus Asset Management, LLC | 139,092 | $4,557,000 | 1.14% |
Redmile Group, LLC | 281,479 | $9,221,000 | 1.06% |
PFM Health Sciences, LP | 978,752 | $32,064,000 | 0.74% |
SENZAR ASSET MANAGEMENT, LLC | 66,300 | $2,172,000 | 0.64% |
REGENTATLANTIC CAPITAL LLC | 176,454 | $5,781,000 | 0.54% |
Polar Capital LLP | 479,967 | $15,724,000 | 0.33% |
Partner Investment Management, L.P. | 22,443 | $735,000 | 0.27% |
Old West Investment Management, LLC | 10,408 | $340,000 | 0.21% |